They found that moderate (7-12 months) and large (>12 months) delays in screening caused 3% and 7% rise in advanced-stage CRC respectively
Delays in the treatment of colorectal cancer (CRC) due to the novel coronavirus pandemic has led to increased death rates, according to a new study presented at the UEG Week Virtual 2020.
For the study, researchers at the University of Bologna designed a model to speculate the impact of time delays in CRC screening on CRC mortality caused by Covid-19.
They found that moderate (7-12 months) and large (>12 months) delays in screening caused 3 per cent and 7 per cent increase in advanced-stage CRC respectively.
They also noticed that based on survival rates at five years for advanced stage III-IV CRC, there has been a significant 11.9 per cent increase in deaths, when comparing a 0-3-month delay to a > 12-month delay.
Also read: Researchers explore inter-relationship between cancer and Covid-19
The reason behind the suspension of CRC screening across Europe is the coronavirus-triggered lockdown and overwhelming numbers of hospitalised Covid-19 patients.
Lead author of the study, Professor Luigi Ricciardiello, said in an official release: “Across the globe, healthcare systems…
Read full article